On February 24, 2021 CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, reported that management will participate in three virtual investor conferences including the Raymond James 42nd Annual Institutional Investors Conference taking place March 1-3, 2021, the H.C. Wainwright Global Life Sciences Conference taking place March 9-10, 2021, and Oppenheimer’s 31st Annual Healthcare Conference taking place March 16-17, 2021 (Press release, CymaBay Therapeutics, FEB 24, 2021, View Source [SID1234575522]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Raymond James 42nd Annual Institutional Investors Conference
Date:
Time:
Webcast: Monday, March 1, 2021
2:10 pm Eastern Time / Track 4
View Source

H.C. Wainwright Global Life Sciences Conference
Date:
Time:
Webcast: Tuesday, March 9 , 2021
On-Demand 7:00 am Eastern Time
View Source

Oppenheimer’s 31st Annual Healthcare Conference
Date:
Time:
Webcast:
Tuesday, March 16, 2021
3:50 pm Eastern Time
View Source